|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09939 KINTOR PHARMA-B
Nominal 
1.805 +0.110 (+6.490%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 52,040 | 769.652% | 32,682 | 5,000 | 0 | 0 |
| Cost of Sales | (26,375) | 326.780% | (24,643) | (9,730) | (42,229) | -- |
| Gross Profit | 25,665 | -- | 8,039 | (4,730) | (42,229) | -- |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | 900 | (1,206) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 4,600 | -- | 766 | (1,429) | 52 | (568) | |
| Profit / (Loss) before Taxation | (78,805) | -5.674% | (202,959) | (155,274) | (1,068,861) | (953,284) | |
| Taxation | 3,023 | 991.336% | 2,852 | (18) | 8,041 | (1,085) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (75,782) | -8.990% | (200,107) | (155,292) | (1,060,820) | (954,369) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 2,083 | -6.843% | 3,944 | 5,068 | (3,387) | 1,305 |
| Depreciation & Amortisation | 18,640 | 47.259% | 33,213 | 17,627 | 18,976 | 18,388 |
| Directors' Emoluments | -- | -- | -- | 10,422 | 27,362 | 18,573 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Disclaimer | Unqualified (Modified Report) | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -15.000 | -21.053% | -44.000 | -36.000 | -247.000 | -253.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.377) | (0.462) | (0.903) | (2.553) |
| NBV per share ($) | 0.219 | -- | 0.366 | 0.657 | 1.024 | 3.341 |
| Remarks: | Real time quote last updated: 21/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -75,782 |
| %Change | -8.990% |
| EPS / (LPS) | RMB -0.150 |
| NBV Per Share (¥) | RMB 0.219 |